Vertex Pharmaceuticals Incorporated announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 1,793.370 million compared to USD 1,524.485 million a year ago. Operating loss was USD 37.961 million compared to operating Income of USD 718.033 million a year ago. Net income was USD 66.924 million compared to USD 837.270 million a year ago. Basic earnings per share from continuing operations was USD 0.26 compared to USD 3.22 a year ago. Diluted earnings per share from continuing operations was USD 0.26 compared to USD 3.18 a year ago. For the half year, total revenue was USD 3,517.675 million compared to USD 3,039.592 million a year ago. Operating income was USD 849.865 million compared to USD 1,438.257 million a year ago. Net income was USD 720.062 million compared to USD 1,440.023 million a year ago. Basic earnings per share from continuing operations was USD 2.78 compared to USD 5.54 a year ago. Diluted earnings per share from continuing operations was USD 2.75 compared to USD 5.46 a year ago.